Cox-2: A New Target for Cancer Prevention and Treatment
Preview
36 Csiki I, Dang T, Gonzalez A, Sandler A, Carbone D, Choy H, Campbell N, Garcia B, Morrow J, Johnson DH: Cyclooxygenase-2 inhibition docetaxel in recurrent non-small cell lung cancer: Preliminary results of a phase II trial (THO- 0054).